Source: BioPortfolio

Kloudscript: KloudScript Specialty Network Now Dispensing Vosevi and Mavyret

KloudScript expands Hepatitis C therapeutic category to include Vosevi and MavyretOakbrook Terrace IL PRWEB August 08 2017 KloudScript is excited to announce the expansion of the Hepatitis C therapeutic category with the latest FDA approved medications Vo...

Read full article »
Kloudscript's Competitors | Kloudscript's News | Kloudscript's Financials
Stay up-to-date with the latest news on KloudScript
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Rinku Patel's photo - Founder & CEO of KloudScript

Founder & CEO

Rinku Patel

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on KloudScript